A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Clinical trial NCT05199272 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05199272
Sponsor: 23andMe, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Clear Cell Renal Cell Carcinoma Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma Neuroendocrine Tumors MSI-H Cancer Cancer With A High Tumor Mutational Burden Extensive-stage Small-cell Lung Cancer

Start date: 2021-12-29
Primary completion: 2025-03-01
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.